News & Updates
Filter by Specialty:

EAGLE trials herald new era for uncomplicated UTI treatment
Oral gepotidacin, an investigational, first-in-class oral antibiotic with a novel mechanism of action, showed favourable signals for the treatment of uncomplicated urinary tract infections (uUTIs), according to the results of two phase III trials.
EAGLE trials herald new era for uncomplicated UTI treatment
25 Apr 2023
What are the risk factors for relapse after methotrexate dose reduction?
For patients with rheumatoid arthritis, a history of cardiovascular disease, gastrointestinal disease, or liver disease, as well as prior use of nonsteroidal anti-inflammatory drugs can contribute to an increased risk of relapse after methotrexate dose reduction, as suggested in a study.
What are the risk factors for relapse after methotrexate dose reduction?
25 Apr 2023
Pregnancy a risk factor for COVID-19 among unvaccinated women
Pregnant women who remain unvaccinated from COVID-19 are at increased risk of contracting COVID-19 when compared with unvaccinated nonpregnant women, as reported in a study for the Philippines.
Pregnancy a risk factor for COVID-19 among unvaccinated women
24 Apr 2023
Telecarers improve treatment, compliance in older hip fracture patients
Telecarers are beneficial in the monitoring of older hip fracture patients who are undergoing osteoporosis treatment, suggests a Singapore study. However, patient or family rejection and physician failure to prescribe persist as limitations of treatment.